Aktiesnakken — Februar 2011
-
godmorgen
-
Godmorgen et nyt dansk biotek selskab http://ing.dk/artikel/116550-lille-biotekselskab-skovler-millioner-ind-til-test-af-lovende-medicin
-
Overvægt af aktier. http://www.teknisk-analyse.dk/blog/index.php?id=ce6
-
Morning
-
Fls ude med regnskab.
-
Mere eller mindre som forventet..
-
30-50% i udbytte!
-
altså af overskuddet
-
@ aka - Der er lagt op til 9 kr. i udbytte
-
Ved kurs 476, er det ikke en speciel god yield.
TYR-BRAS initiativet handler om håndteringen af beriget uran 
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind